Despite this, the need for life sciences companies to use M&A to acquire new capabilities is essential if they are to keep pace with the changing landscape.
Ọtụtụ ụlọ ọrụ na-agba mbọ iji R&D na-enwe ike na-enye ndị ọhụrụ na ha igwe, dị mkpa ma ọ bụrụ na ị chọrọ inye a ọnụ na mkpa atụmatụ na a gbanwee price.